Cargando…
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group
Last year the field of immunotherapy was finally introduced to GI oncology, with several changes in clinical practice such as advanced hepatocellular carcinoma or metastatic colorectal MSI-H. At the virtual ASCO-GI symposium 2021, several large trial results have been reported, some leading to a cha...
Autores principales: | Koessler, Thibaud, Alsina, Maria, Arnold, Dirk, Ben-Aharon, Irit, Lutz, Manfred P., Obermannova, Radka, Peeters, Mark, Sclafani, Francesco, Smyth, Elizabeth, Valle, Juan W., Wagner, Anna Dorothea, Wyrwicz, Lucjan, Fontana, Elisa, Moehler, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381132/ https://www.ncbi.nlm.nih.gov/pubmed/34426663 http://dx.doi.org/10.1038/s41416-021-01474-y |
Ejemplares similares
-
ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective
por: Koessler, T., et al.
Publicado: (2022) -
Highlights of ASCO 2023
por: Neugut, Alfred I, et al.
Publicado: (2023) -
2007 EORTC-NCI-ASCO Annual Meeting: Molecular Markers in Cancer
por: Lukan, C
Publicado: (2008) -
Focused update on Gastrointestinal (GI) Oncology from ASCO 2016
por: Paluri, Ravi Kumar
Publicado: (2016) -
ASCO 2016: highlights in breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2016)